Aehr Test Systems to Announce Fiscal 2021 Fourth Quarter and Full Year Financial Results on July 15, 2021

FREMONT, Calif., July 08, 2021 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced that it will report financial results for its fiscal 2021 fourth quarter and full year ended May 31, 2021 on Thursday, July 15, 2021 following the close of the market. The Company will host a conference call and webcast at 5:00 p.m. Eastern time to discuss the results.

What: Aehr Test Systems fourth quarter fiscal 2021 financial results conference call.
   
When: Thursday, July 15, at 5:00 p.m. Eastern Time (2:00 p.m. PT).
   
Dial in Number: To access the live call, dial 800-367-2403 (US and Canada) or +1 334-777-6978 (International) and give the participant passcode9748167.
   
Webcast:  To access the live webcast, please visit the investor relations section at www.aehr.com.
   
Call
Replay:
A phone replay of the call will be available approximately two hours following the end of the call through 8:00 p.m. ET on Thursday, July 22, 2021. To access the replay dial-in information, please click here.

About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in and testing logic, optical and memory integrated circuits and has installed over 2,500 systems worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products in package, wafer level, and singulated die/module level test. Aehr Test has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for both lower power and higher power logic devices as well as all common types of memory devices. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems used for burn-in and functional test of complex devices, such as leading-edge memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The FOX-CP system is a new low-cost single-wafer compact test and reliability verification solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The WaferPak contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of both bare die and modules. For more information, please visit Aehr Test Systems’ website at www.aehr.com.

Contacts:  
   
Aehr Test Systems MKR Investor Relations Inc.
Ken Spink Todd Kehrli or Jim Byers
Chief Financial Officer Analyst/Investor Contact
(510) 623-9400 x309 (323) 468-2300
  [email protected]



Generation Bio to Present at William Blair Biotech Focus Conference

CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff McDonough, M.D., president and chief executive officer, will present at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, at 9:00 a.m. ET.

A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event.

About Generation Bio

Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary, high-capacity DNA construct called closed-ended DNA, or ceDNA; a cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The platform is designed to enable multi-year durability from a single dose of ceDNA and to allow titration and redosing if needed. The ctLNP is designed to deliver large genetic payloads, including multiple genes, to specific tissues to address a wide range of indications. The company’s efficient, scalable manufacturing process supports Generation Bio’s mission to extend the reach of gene therapy to more people, living with more diseases, in more places around the world.

For more information, please visit www.generationbio.com.

Contact:

Investors

Maren Killackey
Generation Bio
[email protected]
541-646-2420

Media

Alicia Webb
Generation Bio
[email protected]
847-254-4275

Stephanie Simon
Ten Bridge Communications
[email protected]
617-581-9333



FTI Consulting to Release Second Quarter 2021 Results and Host Conference Call

WASHINGTON, July 08, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the second quarter ended June 30, 2021, before the New York market opens on Thursday, July 29, 2021.

A conference call will be held to discuss these financial results on Thursday, July 29, 2021, at 9:00 a.m. Eastern Time and will be hosted by senior management.

The conference call will be simulcast live on the Internet and can be accessed by logging onto the Company’s investor relations website. A replay of the webcast will be available on the Company’s investor relations website for 90 days.

About FTI Consulting

FTI Consulting, Inc. is a global business advisory firm dedicated to helping organizations manage change, mitigate risk and resolve disputes: financial, legal, operational, political & regulatory, reputational and transactional. With more than 6,400 employees located in 29 countries, FTI Consulting professionals work closely with clients to anticipate, illuminate and overcome complex business challenges and make the most of opportunities. The Company generated $2.46 billion in revenues during fiscal year 2020. For more information, visit www.fticonsulting.com.

FTI Consulting, Inc.

555 12th Street NW
Washington, DC 20004
+1.202.312.9100

Investor Contact:

Mollie Hawkes
+1.617.747.1791        
[email protected]

 



Glass Lewis Recommends Genesco Shareholders Vote For Boardroom Change on Legion Partners’ WHITE Proxy Card

Glass Lewis Recommends Genesco Shareholders Vote For Boardroom Change on Legion Partners’ WHITE Proxy Card

Leading Independent Proxy Advisory Firm Concludes Change is Warranted and Supports the Addition of Highly-Qualified, Independent Director Candidates to Genesco’s Board

Glass Lewis Endorses Nominees Dawn H. Robertson and Hobart P. Sichel, Who Have Significant Retail Sector Operations and Turnaround Experience

Glass Lewis Scrutinizes Long-Tenured Directors – Including Matthew C. Diamond – While Highlighting That, “Genesco’s Performance and Returns Have Been Profoundly Substandard by Almost Any Benchmark Over Almost Any Period”

Legion Partners Urges Fellow Shareholders to Vote on the WHITE Proxy Card to Elect its Full Slate, Which Possesses the Expertise, Impartiality and Vision Lacking in Genesco’s Boardroom

LOS ANGELES–(BUSINESS WIRE)–
Legion Partners Asset Management, LLC (together with its affiliates, “Legion Partners” or “we”), which collectively with the other participants in its solicitation beneficially owns approximately 5.9% of the outstanding common shares of Genesco, Inc. (NYSE: GCO) (“Genesco” or the “Company”), today announced that leading independent proxy advisory firm, Glass, Lewis & Co., LLC (“Glass Lewis”), has recommended the Company’s shareholders vote for boardroom change on the WHITE proxy card. In particular, Glass Lewis has endorsed nominees Dawn H. Robertson and Hobart P. Sichel for election to Genesco’s Board of Directors (the “Board”) at the upcoming Annual Meeting of Shareholders (the “Annual Meeting”) on July 20, 2021. Learn about how to vote on Legion Partners’ WHITE proxy card by visiting www.GCOForward.com.

Chris Kiper and Ted White, Legion Partners’ Managing Directors, commented:

“Legion Partners is pleased that Glass Lewis is acknowledging Genesco’s many years of underperformance and recommending the Company’s shareholders vote for sorely-needed boardroom change on the WHITE proxy card. We agree with Glass Lewis’ critique of Genesco’s long-tenured directors, including 20-year director Matthew C. Diamond. We also agree with the manner in which Glass Lewis has critiqued Genesco’s poor corporate governance, underwhelming financial results and weak valuation. By recommending that shareholders vote to elect Ms. Robertson and Mr. Sichel, Glass Lewis is endorsing two proven retail experts with significant experience turning around struggling retailers. We believe shareholders should go a step further to protect their investment by electing all four members of the Legion Partners’ slate.”

In making its recommendation that shareholders vote on the WHITEproxy card, Glass Lewis noted Genesco’s concerning governance, while affirming Legion Partners’ case for change: 1

  • “Genesco’s defense of its longest serving directors quickly falters under the weight of the Company’s dour metrics. With this view in mind, we believethere is ample cause for Genesco to support an incremental degree of board change at this time.”
  • “We consider the timing of [the recent new director] appointments and the contemporaneous departures of Mr. Dickens and Ms. Mason seems to suggest the sitting board may have felt pressured to pursue an accelerated and reactive refresh to blunt Legion’s case[…] we do not consider the process giving rise to the noted appointments reflects favorably on Genesco.”
  • “We note there exists considerable friction in relation to the continued service of Matthew Diamond, whose 20-year tenure more than doubles the next longest serving member of the remaining Genesco board. Despite this objectively lengthy term and related optics surrounding his effective independence, we note the remaining Genesco directors nevertheless tabbed Mr. Diamond to both serve as the board’s lead independent director and chair the nominating and governance committee […] it is both noteworthy and disconcerting that the board saw no glaring issue with vesting critical and notionally independent oversight responsibilities in a two-decade director.”
  • “[…]Genesco’s relative returns during Mr. Diamond’s tenure have been profoundly poor, suggesting that the fundamental preservation and expansion of shareholder value is not a critical input into the deliberative processes giving rise to renominations or key committee appointments. We believe investors should take a very dim view of this framework.”
  • “We further note several of the Dissident’s more incremental alternatives appear to speak directly to established weaknesses at the Company, including what seems to be subpar expense management and pervasively sluggish and substandard digital/e-commerce execution.”
  • “We believe [Ms. Robertson’s] experience speaks directly to a number of fundamental operational concerns at Genesco… we note Ms. Robertson has, in certain cases (e.g. Myer Department Stores, Stein Mart), been retained to implement challenging turnaround strategies […]”
  • “Mr. Sichel would add further retail marketing and incremental e-commerce experience well tailored to Genesco’s current deficiencies, and consider his eight-year C-suite tenure at a Fortune 500 company adequately offsets his lack of prior board service. We would further highlight that between its IPO in October 2013 and the start of August 2019, Burlington generated TSR of 608.2%; over the same period, Genesco generated a dividend adjusted loss of -45.4%.”

In its report, Glass Lewis also highlighted Genesco’s serial financial underperformance and weak operational execution by noting:

  • “Genesco’s performance and returns have been profoundly substandard by almost any benchmark over almost any period.”
  • “Genesco is a serial underperformer with a fairly weak track record of execution and innovation.”
  • “In essence, we are concerned Genesco is not simply moving the goalpost, but replacing it entirely.”
  • “[…] Genesco has routinely failed to reliably offer investors attractive value over the short-, medium- or long-term, has not realized superior performance in the wake of advertised shifts in strategy or executive composition and has weathered a decidedly dour exogenous event substantially worse than other branded and retail footwear firms […]”
  • “Of note on the revenue side is the fact that Genesco’s focus on footwear has failed to drive competitive top-line growth both before and after giving effect to COVID-impacted periods, leaving the Company firmly in the lower third of all peer benchmarks.”
  • “Journey’s [e-commerce penetration] remained well off the pace of similarly situated teen retailers. In simple terms, […] a rising e-commerce tide [during COVID] lifted all boats, but nevertheless left Genesco’s primary footwear retailing segment substantially below comparable trends.”
  • “Genesco’s margins have, in fact,deteriorated over the long term, owing, in no small part, to bloated costs and ineffective management.”

***

Please visit www.GCOForward.com to view important materials.

If you have any needs or require assistance as you consider how to vote, please contact Legion Partners’ proxy solicitor Kingsdale Advisors at [email protected].

***

About Legion Partners

Legion Partners is a value-oriented investment manager based in Los Angeles, with a satellite office in Sacramento, California. Legion Partners seeks to invest in high-quality businesses that are temporarily trading at a discount, utilizing deep fundamental research and long-term shareholder engagement. Legion Partners manages a concentrated portfolio of North American small-cap equities on behalf of some of the world’s largest institutional and high-net-worth investors. Learn more at www.LegionPartners.com.

1 Permission to quote Glass Lewis neither sought nor obtained; emphasis added.

For Investors:

Kingsdale Advisors

Michael Fein / Lydia Mulyk, 646-651-1640

[email protected] / [email protected]

For Media:

MKA

Greg Marose / Charlotte Kiaie, 646-386-0091

[email protected] / [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Consulting Professional Services Finance

MEDIA:

Novocure to Report Second Quarter 2021 Financial Results

Novocure to Report Second Quarter 2021 Financial Results

ST. HELIER, Jersey–(BUSINESS WIRE)–
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2021 on Thursday, July 29, 2021, before the U.S. financial markets open. Novocure’s management will host a conference call and webcast to discuss its financial results for the three and six months ended June 30, 2021, at 8 a.m. EDT on Thursday, July 29, 2021. Analysts and investors can participate in the conference call by dialing 855-442-6895 for domestic callers and 509-960-9037 for international callers, using the conference ID 1926805.

The webcast, earnings slides presented during the webcast and the corporate presentation can be accessed live from the Investor Relations page of Novocure’s website, www.novocure.com/investor-relations, and will be available for at least 14 days following the call. Novocure has used, and intends to continue to use, its investor relations website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

About Novocure

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Tumor Treating Fields are electric fields that disrupt cancer cell division. Novocure’s commercialized products are approved for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma. Novocure has ongoing clinical trials investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.

Headquartered in Jersey, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, Pennsylvania and New York City. Additionally, the company has offices in Germany, Switzerland, Japan and Israel. For additional information about us, visit www.novocure.com or follow us @Novocure on LinkedIn and Twitter.

Forward-Looking Statements

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Novocure’s current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, clinical trial progress, development of potential products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, coverage, collections from third-party payers and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” or other words and terms of similar meaning. Novocure’s performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, environmental, regulatory and political conditions as well as issues arising from the COVID-19 pandemic and other more specific risks and uncertainties facing Novocure such as those set forth in its Annual Report on Form 10-K filed on February 25, 2021 with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Novocure does not intend to update publicly any forward-looking statement, except as required by law. Any forward-looking statements herein speak only as of the date hereof. The Private Securities Litigation Reform Act of 1995 permits this discussion.

Investors:

Ingrid Goldberg

[email protected]

610-723-7427

Media:

[email protected]

610-723-7428

KEYWORDS: Jersey Europe

INDUSTRY KEYWORDS: Biotechnology Health General Health Radiology Pharmaceutical Oncology Medical Devices Research Infectious Diseases Science Clinical Trials

MEDIA:

Logo
Logo

Lawson Products, Inc. to Report Second Quarter 2021 Financial Results

Lawson Products, Inc. to Report Second Quarter 2021 Financial Results

CHICAGO–(BUSINESS WIRE)–Lawson Products, Inc. (NASDAQ: LAWS) (“Lawson” or the “Company”), a distributor of products and services to the MRO marketplace, today announced that it will report its results for the second quarter 2021 on Thursday, July 29, 2021, pre-market. The Company will hold a conference call to review second quarter results beginning at 9:00 a.m. Eastern Time.

Please use the following link to pre-register for this conference call. Callers who pre-register will bypass the live operator on the day of the call. If you pre-register, you will be given a passcode to identify the Lawson call and a unique PIN to gain immediate access to the call. You may pre-register at any time, including up to and after the call start time.

To pre-register please go to:

https://confsignup.callcia.com/Registration/Register?ConferenceId=961026

Please note that pre-registered participants will receive their dial in number upon registration.

Those without internet access or who are unable to pre-register may join on the day of the call by dialing 1-888-506-0062 (domestic); or 1-973-528-0011 (international) and reference Lawson Products. You may access streaming audio of the call through the events calendar on the Investor Relations page of Lawson’s website https://www.lawsonproducts.com/.

A replay of the conference call will be available approximately two hours after the completion of the call through August 31, 2021. Domestic callers can access the replay by dialing 1-877-481-4010; international callers should dial 1-919-882-2331. The PIN access number for the replay is 41933#. You can also access the webcast replay on the Investor Relations page of Lawson’s website through August 31, 2021.

About Lawson Products, Inc.

Founded in 1952, Lawson Products, Inc., headquartered in Chicago, IL, sells and distributes specialty products to the industrial, commercial, institutional and government maintenance, repair and operations market (MRO). The Company is dedicated to helping customers in the U.S. and Canada lower their total cost of operation by increasing productivity and efficiency. The combination of Lawson and Partsmaster’s Managed Inventory process and the Company’s problem-solving professionals ensures customers always have the right parts to handle the job. Through The Bolt Supply House, customers in Western Canada have access to products at several branch locations. Under itsKent Automotive brand, the Company provides collision and mechanical repair products to the automotive aftermarket.

Lawson Products ships from several strategically located distribution centers to customers in all 50 states, Puerto Rico, Canada, Mexico, and the Caribbean.

For additional information, please visit https://www.lawsonproducts.com/ or https://www.kent-automotive.com/.

Investor Relations:

Lawson Products, Inc.

Ronald J. Knutson

Executive Vice President and Chief Financial Officer

773-304-5665

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Other Manufacturing Trucking Construction & Property Aftermarket Automotive Transport Automotive Manufacturing Manufacturing Other Construction & Property

MEDIA:

Logo
Logo

DocGo and Long Island Select Healthcare Commemorate Mobile Health Partnership

DocGo President Anthony Capone to be Honored at Long Island Select Healthcare Five-Year Anniversary Celebration.

PR Newswire

NEW YORK, July 8, 2021 /PRNewswire/ — Ambulnz, Inc., d/b/a DocGo, a leading provider of last-mile telehealth and integrated medical mobility services that has entered into an agreement to merge with Motion Acquisition Corp. (Nasdaq: MOTN), announced that DocGo will be celebrating the five-year anniversary of Long Island Select Healthcare (LISH), with DocGo president Anthony Capone as the event’s honoree.

“I have been so impressed with Anthony and the entire DocGo team. They have created an environment where value, quality, and patient safety are built into the fabric of their organization,” said Dr. James Powell, CEO of LISH. “They are partners that understand the need to create purpose with all their collaborators. DocGo is transforming the vision of LISH. We are so pleased to honor Anthony and the DocGo Team as part of our 5th Anniversary celebration. We are growing our value-based propositions with innovative telehealth opportunities. LISH looks forward to a long and prosperous relationship as we pivot into the future of health care delivery for our most vulnerable patient populations.”

DocGo’s partnership with LISH equips the not-for-profit organization with DocGo’s AI-powered, proprietary technology, and highly trained medical staff to facilitate quality and comprehensive healthcare to Long Island’s underserved community of patients with unique abilities and needs. Through expert care delivery logistics, DocGo offers medical transport, at-home treatment, and other Mobile Health services for LISH’s patients with highly specialized needs. 

“Congratulations to LISH for five years of phenomenal service,” said Anthony Capone, president of DocGo. “Our partnership with LISH empowers us to do incredibly meaningful work, especially given how challenging medical office visits can be for this demographic. Our Mobile Health program and concierge medical services allow them to be cared for in their own environment, where they feel safe and are surrounded by known entities.”

LISH’s Five-Year Anniversary Celebration will be held Thursday, October 7, 2021, at Land’s End in Sayville. This will be the LISH’s first anniversary event.

About DocGo
DocGo is a leading provider of last-mile telehealth and integrated medical mobility services. DocGo is disrupting the traditional four-wall healthcare system by providing care at the scale of humanity. DocGo’s innovative technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient’s home. Together with DocGo’s integrated Ambulnz transportation services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.

About Long Island Select Healthcare:
As a 501(c)(3) non-profit organization, Long Island Select Healthcare, Inc. (LISH) serves more than 7,000 patients at eight strategic locations throughout Suffolk County, NY. They offer more than 16 services at their Article 28 Federally Qualified Health Center (FQHC) and NYS Article 16 Rehabilitation Clinic. LISH provides more than 70,000 annual visits at their sites within Suffolk County.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/docgo-and-long-island-select-healthcare-commemorate-mobile-health-partnership-301327365.html

SOURCE DocGo

Better Choice Announces Increased Insider Participation

NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) — Better Choice Company (NYSE American: BTTR) (“Better Choice”), an animal health and wellness company, announces that insiders have increased their common equity holdings from approximately 2.9 million common shares to approximately 7.6 million shares, representing approximately 26% of the aggregate common equity outstanding. In addition to meaningful insider participation in the recent $40 Million Underwritten Public Offering, this increase in common equity ownership reflects the automatic conversion of outstanding convertible debt and the Series F Preferred into common shares.

Michael Young, Chairman of Better Choice, stated, “We continue to deploy our own capital alongside investors and are excited about the future growth that awaits Better Choice. Following the closing of our recent underwritten public offering, Better Choice has a net cash position of greater than $30.0 million, which will enable our management team to execute on our international and domestic growth plans while simultaneously pursuing strategic M&A opportunities.”

About Better Choice Company, Inc.

Better Choice Company Inc. is a growing animal health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. We take an alternative, nutrition-based approach to animal health relative to conventional dog and cat food offerings and position our portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. We have a demonstrated, multi-decade track record of success selling trusted animal health and wellness products and leverage our established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. We sell the majority of our dog food, cat food and treats under the Halo and TruDog brands, which are focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats. For more information, please visit https://www.betterchoicecompany.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:

Better Choice Company, Inc.
Scott Lerner, CEO

Investor Contact:

KCSA Strategic Communications
Valter Pinto, Managing Director
PH: 212-896-1254
[email protected]



Budderfly Signs Nationwide Agreement with Lennox International for HVAC Equipment and Services

Company’s Energy Efficiency-as-a-Service Strengthened with Lennox’ Turn-Key Product, Installation, and Maintenance

PR Newswire

SHELTON, Conn., July 8, 2021 /PRNewswire/ — Budderfly, the fastest-growing firm in the North American Energy Efficiency-as-a-Service (EEaaS) market, today announced the company has partnered with Lennox International (NYSE: LII), a global leader in the heating, ventilation, air conditioning, and refrigeration markets. The nationwide agreement allows Budderfly to quickly scale its no upfront cost HVAC replacement program with the addition of Lennox® Model L™, an ultra-high efficiency rooftop unit, as well as expert service and maintenance on Lennox and other HVAC brands. For information on Budderfly’s HVAC replacement program, please visit www.budderfly.com/landing/hvac-contact.

“Budderfly’s EEaaS is truly unique in the industry, and our Model L rooftop unit is the perfect complement to enable them to replace inefficient HVACs that cost their customers thousands of wasted dollars in bloated energy bills,” said Stephanie Leslie, National Account New Business Development Manager, Lennox Commercial. “We are proud to partner with such a progressive organization making it easy for companies to upgrade their environmental infrastructure and reduce their carbon footprint.”

The Lennox partnership is part of Budderfly’s multi-component energy optimization program created in part to service national accounts in industries such as assisted living facilities, community centers, offices, quick service restaurants, retail locations, universities, and other vertical markets with multiple locations. Under the agreement, these types of companies eligible for HVAC upgrades will receive—at no upfront cost—new HVAC units and a dedicated Lennox support team for each of their locations.

“Many of our customers inherit old HVAC units through their lease agreements and are left to fend for themselves when it comes to service and maintenance,” said Al Subbloie, CEO, Budderfly. “The Lennox Model L rooftop unit allows us to bring the lowest HVAC total cost of ownership with the highest impact on efficiency and sustainability to our customers through a no-hassle installation program, so they can concentrate on growing their businesses. We’ve been impressed with Lennox’ support for the partnership and excited to see new and existing customers’ interest in our HVAC program has exceeded expectations.”

For more information about the Model L, visit https://www.lennoxcommercial.com/l

About Lennox International

Lennox International Inc. is a global leader in energy-efficient climate-control solutions. Dedicated to sustainability and creating comfortable and healthier environments for our residential and commercial customers while reducing their carbon footprint, we lead the field in innovation with our air conditioning, heating, indoor air quality, and refrigeration systems. Lennox International stock is listed on the New York Stock Exchange and traded under the symbol “LII”. Additional information on Lennox International is available at www.lennoxinternational.com or by contacting Steve Harrison, Vice President, Investor Relations, at 972-497-6670.

About Budderfly

Budderfly is disrupting the energy industry by leading the digital transformation of energy consumption conservation through its unique Budderfly EnergyCloud™ Energy-Efficiency-as-a-Service model. With no upfront cost to its customers, Budderfly implements proprietary energy intelligence software, energy efficiency upgrades such as LED lights, HVAC replacements and upgrades, variable frequency drives, refrigeration controls, options for comprehensive maintenance, and much more, that span more than 20 savings categories.

Budderfly creates networks of patented IoT devices that meter and report on all elements of energy use. Together these optimize energy usage at the point of consumption within each facility across the enterprise. Budderfly’s ongoing services and proactive maintenance ensure that a building’s energy infrastructure never becomes outdated. The result is significant, immediate, and progressive energy expense savings, upgraded facilities, and a reduced carbon footprint for its client facilities. For more information visit www.budderfly.com or follow us on Twitter @BudderflyEnergy.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/budderfly-signs-nationwide-agreement-with-lennox-international-for-hvac-equipment-and-services-301327349.html

SOURCE Budderfly

Lithia & Driveway (LAD) Schedules Release of Second Quarter 2021 Results

PR Newswire

MEDFORD, Ore., July 8, 2021 /PRNewswire/ — Lithia & Driveway (NYSE: LAD) announced its second quarter 2021 earnings will be released before the market opens on Wednesday, July 21, 2021.  A conference call to discuss the earnings results is scheduled for the same day at 10:00 a.m. Eastern Time.

How to Participate

The conference call may be accessed by telephone at (877) 407-8029. To listen live on our website or for replay, visit www.lithiainvestorrelations.com and click on webcasts.

About Lithia & Driveway (LAD)

LAD is a growth company powered by people and innovation with a 5-year plan to profitably consolidate the largest retail sector in the country. As the leading provider of personal transportation solutions in the United States, LAD is among the fastest-growing companies in the Fortune 500 (#2 on 10-Year EPS Growth, #3 on 10-Year TSR and #12 on 10-year Revenue growth in 2021). By providing a wide array of products and services for the entire vehicle ownership lifecycle through various consumer channels, they build magnetic brand loyalty. Operational excellence is achieved by focusing the business on convenient and transparent consumer experiences supported by proprietary data science to improve market share, consumer loyalty and profitability. LAD’s omni-channel strategy will continue to pragmatically disrupt the industry by leveraging experienced teams, vast owned inventories, technology, and physical network. Continuing to lead the industry’s consolidation and Driveway’s e-commerce in-home experiences further accelerates the massive regenerating capital engine. Together, these endeavors create a unique and compelling high-growth strategy that provides transportation solutions wherever, whenever, and however consumers desire.

Sites

www.lithiamotors.com

www.lithiainvestorrelations.com

www.lithiacareers.com

www.driveway.com

Lithia & Driveway on Facebook

http://www.facebook.com/LithiaMotors

http://www.facebook.com/DrivewayHQ

Lithia & Driveway on Twitter

http://twitter.com/LithiaMotors

http://twitter.com/DrivewayHQ

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lithia–driveway-lad-schedules-release-of-second-quarter-2021-results-301327615.html

SOURCE Lithia Motors, Inc.